RECENT POSTS

dr-horacio-bach-featured

31

Mar, 2020

Dr. Horacio Bach – receives major grant from CIHR for COVID-19 antibody development

By: | Tags: | Comments: 0

An amazing show  of public support for UBC disease researcher Dr. Horciao Bach, who has started his COVID-19 antibody development project.  Dr. Horacio Bach is one of BioMark’s scientific advisors and is expert on antibody engineering.  He has received a major grant from CIHR for COVID- 19 antibody development. More information can be found at @DiseasesUbc

READ MORE

31

May, 2019

National research team targets glioblastoma

By: | Tags: | Comments: 0

MAY 31, 2019 —  Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults and is characterized by its infiltrative and often fatal progression. The strikingly poor survival for patients with GBM of 14-16 months following diagnosis is due in part to limited early detection methods and an absence of effective treatment options. Funding from the Canadian Institute of Health Research of $753,432 was awarded to professor Donald Miller…

READ MORE